Transplantation of co-microencapsulated hepatocytes and HUVECs for treatment of fulminant hepatic failure

被引:10
|
作者
Qiu, Liyuan [1 ,2 ]
Wang, Jian [3 ]
Wen, Xinyu [4 ]
Wang, Haibin [1 ,2 ]
Wang, Yan [1 ,2 ]
Lin, Qiuxia [1 ,2 ]
Du, Zhiyan [1 ,2 ]
Duan, Cuimi [1 ,2 ]
Wang, Chunren [3 ]
Wang, Changyong [1 ,2 ]
机构
[1] Acad Mil Med Sci, Inst Basic Med Sci, Dept Adv Interdisciplinary Studies, Beijing 100850, Peoples R China
[2] Acad Mil Med Sci, Tissue Engn Res Ctr, Beijing 100850, Peoples R China
[3] Natl Inst Control Pharmaceut & Biol Prod, Beijing, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Biochem, Beijing, Peoples R China
来源
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS | 2012年 / 35卷 / 06期
关键词
Co-microencapsulated; FHF; Hepatocyte; HUVEC; Transplantation; MARROW STEM-CELLS; LIVER-FAILURE; INTRASPLENIC TRANSPLANTATION; PORCINE HEPATOCYTES; ENDOTHELIAL-CELLS; IMPROVED SURVIVAL; RATS; ISLETS; COENCAPSULATION; HEPATECTOMY;
D O I
10.5301/ijao.5000092
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Purpose: Microencapsulated hepatocytes might solve immunological rejection, broadening a new perspective for the treatment of fulminant hepatic failure (FHF). However, the transplantation of microcapsulated hepatocytes is limited by low cell viability. Nevertheless, the.co-microencapsulation of hepatocytes and human umbilical vein endothelial cells (HUVECs) may make the treatment of FHF more promising. Methods: We prepared the microcapsules using the high-voltage electrostatic droplet spray method, transplanted the empty microcapsules, isolated hepatocytes, microcapsulated hepatocytes, and co-microencapsulated hepatocytes and HUVEC intraperitoneally into rat models of FHF induced by D-aminogalactose (D-gal). After 1, 3, and 7 days, and 2, 3, and 4 weeks posttransplantation, we calculated the mortality and assessed alanine aminotransferase (ALT), aspartate aminotransferase (AST), and albumin (ALB) levels in the serum of the model; evaluated the integrality and recovery of microcapsules; and stained with hematoxylin and eosin (H&E) the recovered microcapsules as well as the liver of the FHF rats. Results: Hepatocyte-specific functions, including the levels of ALT, AST and ALB in the serum of the co-microencapsulation group, were significantly better than those in the other groups (p < 0.05) from 2 to 4 weeks after transplantation. Moreover, cotransplantation of the microencapsulated hepatocytes and HUVECs decreased the mortality rate of the FHF rats. The recovered microcapsules were intact, and recovery was up to 90%. H&E staining showed that the microencapsulated cells were still alive, and the liver tissues had started to recover after 4 weeks posttransplantation. Conclusion: The microcapsules have good biocompatibility and immunoprotection to protect the hepatocytes from immunological rejection. Cotransplantation of the microencapsulated hepatocytes and HUVECs could decrease mortality rates and improve liver function in FHF
引用
收藏
页码:458 / 465
页数:8
相关论文
共 45 条
  • [1] Testing of microencapsulated porcine hepatocytes in a new model of fulminant liver failure in baboons
    Machaidze, Zurab
    Yeh, Heidi
    Wei, Lingling
    Schuetz, Christian
    Carvello, Michele
    Sgroi, Antonino
    Smith, Rex N.
    Schuurman, Henk-Jan
    Sachs, David H.
    Morel, Philippe
    Markmann, James F.
    Buhler, Leo H.
    XENOTRANSPLANTATION, 2017, 24 (03)
  • [2] Alginate Microencapsulated Hepatocytes Optimised for Transplantation in Acute Liver Failure
    Jitraruch, Suttiruk
    Dhawan, Anil
    Hughes, Robin D.
    Filippi, Celine
    Soong, Daniel
    Philippeos, Christina
    Lehec, Sharon C.
    Heaton, Nigel D.
    Longhi, Maria S.
    Mitry, Ragai R.
    PLOS ONE, 2014, 9 (12):
  • [3] Alginate microencapsulated human hepatocytes for the treatment of acute liver failure in children
    Dhawan, Anil
    Chaijitraruch, Nataruks
    Fitzpatrick, Emer
    Bansal, Sanjay
    Filippi, Celine
    Lehec, Sharon C.
    Heaton, Nigel D.
    Kane, Pauline
    Verma, Anita
    Hughes, Robin D.
    Mitry, Ragai R.
    JOURNAL OF HEPATOLOGY, 2020, 72 (05) : 877 - 884
  • [4] Living donor liver transplantation for fulminant hepatic failure
    Matsui, Yucihi
    Sugawara, Yasuhiko
    Yamashiki, Noriyo
    Kaneko, Junichi
    Tamura, Surnihito
    Togashi, Junichi
    Makuuchi, Masatoshi
    Kokudo, Norihiro
    HEPATOLOGY RESEARCH, 2008, 38 (10) : 987 - 996
  • [5] Intrahepatic transplantation of hepatic oval cells for fulminant hepatic failure in rats
    Chen-Xuan Wu
    Key Laboratory of Artificial Cells of Tianjin
    Zou Q
    Zou Q analyzed the data
    Wang YJ and Wu CX wrote the paper.Supported by Tianjin Science Committee
    World Journal of Gastroenterology, 2009, 15 (12) : 1506 - 1511
  • [6] Intrahepatic transplantation of hepatic oval cells for fulminant hepatic failure in rats
    Wu, Chen-Xuan
    Zou, Qi
    Zhu, Zheng-Yan
    Gao, Ying-Tang
    Wang, Yi-Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (12) : 1506 - 1511
  • [7] Transplantation of microencapsulated umbilical-cord-blood-derived hepatic-like cells for treatment of hepatic failure
    Zhang, Fang-Ting
    Wan, Hui-Juan
    Li, Ming-Hua
    Ye, Jing
    Yin, Mei-Jun
    Huang, Chun-Qiao
    Yu, Jie
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (07) : 938 - 945
  • [8] Long-term effect of hepatocyte transplantation on fulminant hepatic failure in rats
    Ahmad, TA
    Fujioka, H
    Eguchi, S
    Yanaga, K
    Kamohara, Y
    Furui, J
    Kanematsu, T
    HEPATO-GASTROENTEROLOGY, 2003, 50 (50) : 467 - 471
  • [9] Liver transplantation and artificial liver support in fulminant hepatic failure
    Zhu, XF
    Chen, GH
    He, XS
    Lu, MQ
    Wang, GD
    Cai, CJ
    Yang, Y
    Huang, JF
    WORLD JOURNAL OF GASTROENTEROLOGY, 2001, 7 (04) : 566 - 568
  • [10] Fulminant hepatic failure: etiology, management and indications for liver transplantation
    Lucena da Fonseca-Neto, Olival Cirilo
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2008, 21 (04): : 201 - 204